【摘要】 肝转移瘤临床中较为常见,35%～50%来源于腹部肿瘤。肝转移瘤有较为特异的影像学特征。近年来,手术、介入、立体定向放疗在肝转移瘤治疗方面的应用得到了延伸。对于大肠癌肝转移,全身化疗仍占主导地位。一线方案包括FOLFOX、FOLFIRI、5FU/叶酸、CAPOX、IFL联合贝伐单抗等方案,二线治疗包括FOLFOX、FOLFIRI、单药伊立替康、伊立替康联合西妥昔单抗等,AVASTIN、ERBITUX等分子靶向治疗处于研究的最前沿,改善了晚期结肠癌患者的生存指标,确定了其在该领域治疗的主导地位。更多还原

【Abstract】 Metastatic neoplasm of liver is common, 35 to 50 percent of which is from abdomen carcinoma. It has some special character in iconography. Recent years, the application of operation, intervention and three dimensional-stereotactic radiotherapy makes further progression in its treatment. While, chemotherapy still plays the dominant role. The first-line regimen includes FOLFOX? FOLFIRI? and IFL combined with AVASTIN etc. Further more, molecular target therapy such as AVASTIN and ERBITUX is the latest research. These drugs benefit the survival of advanced colorectal carcinoma patients, which also ensures its new position in treatment.更多还原